Improved metabolic control after 12-week dietary intervention with low glycaemic isomalt in patients with type 2 diabetes mellitus

Hormone and Metabolic Research

Volumn 41, Issue 12, 2009, Pages 886-892

  Holub, I ^a   Gostner, A ^a   Hessdorfer S ^a   Theis, S ^b   Bender, G ^a   Willinger, B ^a   Schauber, J ^a,c   Melcher, R ^a   Allolio, B ^a   Scheppach, W ^a,d  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b BENEO GmbH   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d Clinic of Dermatology and Allergology ^*  (Germany)

Author keywords

Carbohydrate metabolism; Glycaemic index; Glycaemic load

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; C PEPTIDE; CARBOHYDRATE; FATTY ACID; FRUCTOSAMINE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; ISOMALT; LIPID; MALTODEXTRIN; METFORMIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PROINSULIN; STARCH HYDROLYSATE; SUCROSE;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD EXAMINATION; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; DIABETIC PATIENT; DIET; DIET RESTRICTION; DIET SUPPLEMENTATION; DIET THERAPY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOOD INTAKE; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC CONTROL; GLYCEMIC LOAD; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MALE; MEDICAL EXAMINATION; METABOLIC PARAMETERS; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT DURATION; TREATMENT OUTCOME;

ADIPOKINES; BODY WEIGHT; CARBOHYDRATE METABOLISM; CARIOGENIC AGENTS; DIABETES MELLITUS, TYPE 2; DIET; DISACCHARIDES; FECES; FEMALE; GLYCEMIC INDEX; HUMANS; LIPIDS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RISK FACTORS; SUGAR ALCOHOLS; TIME FACTORS;

EID: 71849099296     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0029-1234107     Document Type: Article

References (38)

1. Yach D, Stuckler D, Brownell KD. Epidemiology and economic consequences of the global epidemics of obesity and diabetes. Nat Med 2006 12 62-66
2. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001 414 782-787
3. Dickinson S, Brand-Miller J. Glycemic index, postprandial glycemia and cardiovascular disease. Curr Opin Lipidol 2005 16 69-75
4. Ludwig DS, Eckel HE. The glycemic index at 20 y. Am J Clin Nutr 2002 76 S264-S265
5. Livesey G, Buss D, Coussement P, Edwards DG, Howlett J, Jonas DA, Kleiner JE, Müller D, Sentko A. Suitability of traditional energy values for novel foods and food ingredients. Food Control 2000 11 249-289
6. Gehring F, Karle EJ. Sweetening agent, Palatinit under specific consideration as to microbiological and caries-prophylactic aspects. Z Ernährungswiss 1981 20 96-106
7. Langkilde AM, Andersson H, Schweizer TF, Wursch P. Digestion and absorption of sorbitol, maltitol and isomalt from small bowel. A study in ileostomy subjects. Eur J Clin Nutr 1994 48 768-775
8. Life Science Research Office. The Evaluation of the Energy of Certain Sugar Alcohols used as Food Ingredients Bethesda, MD: Life Science Research Office, Federation of the American Society for Experimental Biology 1994
9. Livesey G. Health potential of polyols as sugar replacers, with emphasis on low glyceamic properties. Nutr Res Rev 2003 16 163-289
10. Bär A. Factorial calculation model fort he estimation of the physiological caloric value of polyols. In: Hosoxa N, ed Proceedings of the International Symposium on Caloric Evaluation of Carbohydrates Tokyo: Research Foundation for Sugar Metabolism 1990 209-257
11. Atkinson FS, Foster-Powell K, Brand-Miller JC. International tables of glycemic index and glycemic load values: 2008. Diabetes Care 2008 31 2281-2283
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419
13. Gostner A, Schäffer V, Theis S, Menzel T, Lührs H, Melcher R, Schauber J, Kudlich T, Dusel G, Dorbath D, Kozianowski G, Scheppach W. Effects of isomalt consumption on gastrointestinal and metabolic parameters in healthy volunteers. Br J Nutr 2005 94 575-581
14. Brand-Miller J, Hayne S, Petocz P, Colagiuri S. Low-glycemic index diets in the management of diabetes: a meta-analysis of randomized controlled trials. Diabetes Care 2003 26 2261-2267 (Pubitemid 36993310)
15. Opperman AM, Venter CS, Oosthuizen W, Thompson RL, Vortser HH. Meta-analysis of the health effects of using the glycemic index in meal-planning. Br J Nutr 2004 92 367-381
16. Livesey G, Taylor R, Hulshof T, Howlett J. Glycemic response and health a systematic review and meta-analysis: relations between dietary glycemic properties and health outcomes. Am J Clin Nutr 2008 87 (Suppl) 258S-268S
17. Tushuizen ME, Diamant M, Heine RJ. Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes. Postgrad Med J 2005 81 1-6
18. Ginsberg HN, Illingworth DR. Postprandial dyslipidemia: an atherogenic disorder common in patients with diabetes mellitus. Am J Cardiol 2001 88 9H-15H
19. Gokulakrishnan K, Deepa R, Velmurugan K, Ravikumar R, Karkuzhali K, Mohan V. Oxidised low-density lipoprotein and intimal medial thickness in subjects with glucose intolerance: the Chennai Urban Rural Epidemiology Study-25. Metabolism 2007 56 245-250
20. Hawkins M, Tonelli J, Kishore P, Stein D, Ragucci E, Gitig A, Reddy K. Contribution of elevated free fatty acid levels to the lack of glucose effectiveness in type 2 diabetes. Diabetes 2003 52 2748-2758
21. Pilz S, Scharnagl H, Tiran B, Seelhorst U, Wellnitz B, Boehm BO, Schaefer JR, Marz W. Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease. J Clin Endocrinol Metab 2006 91 2542-2547
22. Rizkalla SW, Taghrid L, Laromiguiere M, Huet D, Boillot J, Rigoir A, Elgrably F, Slama G. Improved plasma glucose control, whole-body glucose utilization, and lipid profile on a low-glycemic index diet in type 2 diabetic men: a randomized controlled trial. Diabetes Care 2004 27 1866-1872
23. Ren S, Lee H, Hu L, Lu L, Shen GX. Impact of diabetes-associated lipoproteins on generation of fibrinolytic regulators from vascular endothelial cells. J Clin Endocrinol Metab 2002 87 286-291
24. Juhan-Vague I, Alessi MC. PAI-1, obesity, insulin resistance and risk of cardiovascular events. Thrombosis and haemostasis 1997 78 656-660
25. Clausen P, Feldt-Rassmussen B, Jensen G, Jensen JS. Endothelial haemostatic factors are associated with progression of urinary albumin excretion in clinically healthy subjects: a 4-year prospective study. Clin Sci 1999 97 37-43
26. Hayden MR, Tyagi SC. Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutr Metab (Lond) 2004 1 10
27. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006 116 1784-1792
28. Rothenbacher D, Brenner H, Marz W, Koenig W. Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. Eur Heart J 2005 26 1640-1646
29. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001 86 1930-1935
30. Qi L, Meigs JB, Liu S, Manson JE, Mantzoros C, Hu FB. Dietary fibers and glycemic load, obesity, and plasma adiponectin levels in women with type 2 diabetes. Diabetes Care 2006 29 1501-1505
31. Anderlova K, Kremen J, Dolezalova R, Housova J, Haluzikova D, Kunesova M, Haluzik M. The influence of very-low-calorie diet on serum leptin, soluble leptin receptor, adiponectin and resistin levels in obsese women. Physiol Res 2006 55 277-283
32. Bouche C, Rizkalla SW, Luo J, Vidal H, Veronese A, Pacher N, Fouquet C, Lang V, Slama G. Five-week, low-glycemic index diet decreases total fat mass and improves plasma lipid profile in moderately overweight nondiabetic men. Diabetes Care 2002 25 822-828
33. McMillan-Price J, Petocz P, Atkinson F, ONeill K, Samman S, Steinbeck K, Caterson I, Brand-Miller J. Comparison of 4 diets of varying glycemic load on weight loss and cardiovascular risk reduction in overweight and obese young adults: a randomized controlled trial. Arch Intern Med 2006 166 1466-1475
34. Ebbeling CB, Leidig MM, Sinclair KB, Hangen JP, Ludwig DS. A reduced-glycemic load diet in the treatment of adolescent obesity. Arch Pediatr Adolesc Med 2003 157 773-779
35. Williams KV, Kelley DE. Metabolic consequences of weight loss on glucose metabolism and insulin action in type 2 diabetes. Diabetes Obes Metab 2000 2 121-129
36. Wing RR, Koeske R, Epstein LH, Nowalk MP, Gooding W, Becker D. Long-term effects of modest weight loss in type II diabetes patients. Arch Intern Med 1987 147 749-753
37. Watts NB, Spanheimer RG, DiGirolamo M, Gebhart SS, Musey VC, Siddig YK, Phillips LS. Prediction of glucose response to weight loss in patients with non-insulin-dependent diabetes mellitus. Arch Intern Med 1990 150 803-806
38. Blonk MC, Jacobs MA, Biesheuvel EH, Weeda-Mannak WL, Heine RJ. Influences on weight loss in type 2 diabetic patients: little long-term benefit from group behaviour therapy and exercise training. Diabet Med 1994 11 449-457